by Xcellerant Ventures | Dec 29, 2021 | Portfolio Company News
Content origionally posted on Forbes: https://www.forbes.com/profile/nanodropper/?sh=68bd9c044196 About Nanodropper Song, Baker, Andrews and Steger cofounded Nanodropper, a patented twist-on adapter that produces eye drops with 70% less volume than a normal eye drop,...
by Xcellerant Ventures | Dec 15, 2021 | Portfolio Company News
Content origionally posted on The EPOCH Times: https://www.theepochtimes.com/us/health-app-that-tracks-response-to-diseases-rated-no-1-by-cedars-sinai-medical-center-4159309?welcomeuser=1 A unique health app that allows patients to track how treatments, medications,...
by Xcellerant Ventures | Oct 21, 2021 | Portfolio Company News
Content origionally posted on Greenwich Sentinel: https://www.greenwichsentinel.com/2022/06/15/local-doctors-prescription-addresses-environmental-financial-concerns/ Like broken records, Dr. James Murphy’s patients had been bringing him the same repertoire of...
by Xcellerant Ventures | Oct 21, 2021 | Portfolio Company News
Content origionally posted on Mayo Clinic’s blog: https://newsnetwork.mayoclinic.org/discussion/alumni-eyes-on-the-patient/ Editor’s Note: This article is the first in the Young Innovators series, originally published in Mayo Clinic’s Alumni...
by Xcellerant Ventures | Oct 13, 2021 | Portfolio Company News
Content origionally from PR News wire: https://www.prnewswire.com/news-releases/john-shufeldt-md-joins-tesis-labs-board-of-directors-301398790.html PHOENIX, Oct. 13, 2021 /PRNewswire/ — Tesis Labs, a leader in targeted genetic sequencing, announced today the...
by Xcellerant Ventures | Oct 5, 2021 | Portfolio Company News
Content origionally from PR Newsire: https://www.prnewswire.com/news-releases/tesis-labs-raises-20-million-in-growth-equity-capital-to-expand-clinical-capacity-301392610.html PHOENIX, Oct. 5, 2021 /PRNewswire/ — Tesis Labs, a leader in targeted genetic...
